The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies
Open accessAbstract
Introduction: Although reproductive factors have been known for decades to be associated with breast cancer risk, it is unclear to what extent these associations differ by estrogen and progesterone receptor (ER/PR) status. This report presents the first meta-analysis of results from epidemiological studies that have investigated parity, age at first birth, breastfeeding, and age at menarche in relation to ER+PR+ and ER-PR- cancer risk. Materials and methods: We calculated summary relative risks (RRs) and corresponding 95% confidence intervals (CIs) using a fixed effects model. Results: Each birth reduced the risk of ER+PR+ cancer by 11% (RR per birth = 0.89, 95% CI = 0.84–0.94), and women who were in the highest age at first birth category had, on average, 27% higher risk of ER+PR+ cancer compared with women who were in the youngest age at first birth category (RR = 1.27, 95% CI = 1.07–1.50). Neither parity nor age at first birth was associated with the risk of ER-PR- cancer (RR per birth = 0.99, 95% CI = 0.94–1.05; RR of oldest versus youngest age at first birth category = 1.01, 95% CI = 0.85–1.20). Breastfeeding and late age at menarche decreased the risk of both receptor subtypes of breast cancer. The protective effect of late age at menarche was statistically significantly greater for ER+PR+ than ER-PR- cancer (RR = 0.72 for ER+PR+ cancer; RR = 0.84 for ER-PR- cancer, p for homogeneity = 0.006). Conclusion: Our findings suggest that breastfeeding (and age at menarche) may act through different hormonal mechanisms than do parity and age at first birth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
The Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,439
Methods for Trend Estimation from Summarized Dose-Response Data, with Applications to Meta-Analysis
Greenland, S., & Longnecker, M. P. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116237 · Cited by 2,353
Reproductive Factors and Breast Cancer
Kelsey, J. L., Gammon, M. D., & John, E. M. (1993) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036115 · Cited by 1,446
Current Models of Steroid Hormone Action: A Critique
Gorski, J., & Gannon, F. (1976) · Annual Review of Physiology · doi:10.1146/annurev.ph.38.030176.002233 · Cited by 705
Endogenous Hormones and Breast Cancer Risk
Bernstein, L., & Ross, R. K. (1993) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036116 · Cited by 691
Self-citationThe role of oestrogens and progestagens in the epidemiology and prevention of breast cancer
Key, T. J. A., & Pike, M. C. (1988) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(88)90173-3 · Cited by 651
Self-citationEtiology of Hormone Receptor–Defined Breast Cancer: A Systematic Review of the Literature
Althuis, M. D., Fergenbaum, J. H., Garcia-Closas, M., Brinton, L. A., Madigan, M. P., & Sherman, M. E. (2004) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.1558.13.10 · Cited by 628
Endogenous hormones as a major factor in human cancer.
Henderson, B. E., Ross, R. K., Pike, M. C., & Casagrande, J. T. (1982) · PubMed · Cited by 602
Self-citationRisk Factors for Breast Cancer According to Estrogen and Progesterone Receptor Status
Colditz, G. A., Rosner, B. A., Chen, W. Y., Holmes, M. D., & Hankinson, S. E. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh025 · Cited by 533
Breast cancer, stem/progenitor cells and the estrogen receptor
Dontu, G., El-Ashry, D., & Wicha, M. S. (2004) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2004.05.011 · Cited by 288
Huang, W.-Y., Newman, B., Millikan, R. C., Schell, M. J., Hulka, B. S., & Moorman, P. G. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010265 · Cited by 278
Potter, J. D., Cerhan, J. R., Sellers, T. A., McGovern, P. G., Drinkard, C. R., Kushi, L. H., & Folsom, A. R. (1995) · PubMed · Cited by 248
Anderson, E. (2002) · Breast Cancer Research · doi:10.1186/bcr452 · Cited by 242
Estrogen and Sex Hormone-Binding Globulin Levels in Nulliparous and Parous Women 2
(1985) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/74.4.741 · Cited by 222
Chapter 8: Estrogen Receptor-Mediated Processes in Normal and Cancer Cells
Dickson, R. B., & Stancel, G. M. (2000) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a024237 · Cited by 168
Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology
Ursin, G., Bernstein, L., Lord, S. J., et al. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602712 · Cited by 144
Self-citationCotterchio, M., Kreiger, N., Theis, B., Sloan, M., & Bahl, S. (2003) · PubMed · Cited by 141
The shape of age–incidence curves of female breast cancer by hormone-receptor status
Yasui, Y., & Potter, J. D. (1999) · Cancer Causes & Control · doi:10.1023/a:1008970121595 · Cited by 128
García‐Closas, M., Herbstman, J. B., SCHIFFMAN, M. H., Glass, A. G., & Dorgan, J. F. (2002) · International Journal of Cancer · doi:10.1002/ijc.10651 · Cited by 108
Ma, H., Bernstein, L., Ross, R. K., & Ursin, G. (2006) · Breast Cancer Research · doi:10.1186/bcr1514 · Cited by 107
Self-citationHormone Receptors and Breast Cancer
Habel, L. A., & Stanford, J. L. (1993) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036107 · Cited by 106
ESTROGEN RECEPTORS AND BREAST CANCER
Stanford, J. L., Szklo, M., & Brinton, L. A. (1986) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036295 · Cited by 104
Dorgan, J. F., Reichman, M. E., Judd, J. T., Brown, C., Longcope, C., Schatzkin, A. G., Campbell, W. S., Franz, C., Kahle, L., & Taylor, P. R. (1995) · PubMed · Cited by 100
Chu, K. C., & Anderson, W. F. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1016361932220 · Cited by 95
Britton, J. A. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf065 · Cited by 75
Breast cancer risk factors according to joint estrogen receptor and progesterone receptor status
Rusiecki, J. A., Holford, T. R., Zahm, S. H., & Zheng, T. (2005) · Cancer Detection and Prevention · doi:10.1016/j.cdp.2005.07.004 · Cited by 46
Cited by
Breastfeeding and maternal health outcomes: A systematic review and meta-analysis
Chowdhury, R., Sinha, B., Sankar, M. J., Taneja, S., Bhandari, N., Rollins, N., Bahl, R., & Martines, J. (2015) · Acta Paediatrica · doi:10.1111/apa.13102 · Cited by 1,143
Dissemination and publication of research findings: an updated review of related biases
Song, F., Parekh, Hooper, L., Loke, Y., Ryder, J., Sutton, A., Hing, C., Kwok, C., Pang, C., & Harvey, I. (2010) · Health Technology Assessment · doi:10.3310/hta14080 · Cited by 1,039
Epidemiological characteristics of and risk factors for breast cancer in the world
Momenimovahed, Z., & Salehiniya, H. (2019) · Breast Cancer: Targets and Therapy · doi:10.2147/bctt.s176070 · Cited by 1,050
Key steps for effective breast cancer prevention
Britt, K. L., Cuzick, J., & Phillips, K.-A. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0266-x · Cited by 992
Epidemiology of basal-like breast cancer
Millikan, R. C., Newman, B., Tse, C.-K., Moorman, P. G., Conway, K., Smith, L. V., Labbok, M. H., Geradts, J., Bensen, J. T., Jackson, S., et al. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9632-6 · Cited by 886
Metadata
- Authors
- Ma, H., Bernstein, L., Pike, M. C., & Ursin, G.
- Venue
- Breast Cancer Research
- Published
- 2006-07-19
- Volume
- 8
- Issue
- 4
- Pages
- R43-R43
- ISSN
- 1465-5411 (ISSN-L)
- 1465-542X
- OpenAlex
- W2170402287
- Cited by
- 415
- References
- 28
- FWCI
- 1.09
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.